Long Daniel D.
SEC CIK 2040349 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SEPN | Septerna, Inc. | SVP, Drug Discovery | 99.7K | — | $951.3K | 9 | 2025-11-10 | 2026-09-01 |
Most active insiders at SEPN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | RA CAPITAL MANAGEMENT, L.P. | Dir, 10% | — | $63.45M |
| 2 | Shaikhly Samira | CHRO | — | $2.80M |
| 3 | Bhatt Elizabeth | Pres, COO | — | $1.45M |
| 4 | Long Daniel D. | SVP, Drug Discovery | — | $951.3K |
| 5 | Third Rock Ventures V, L.P. | 10% | — | -$7.40M |
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-09-03 19:01 | 2026-09-01 | SEPN | Septerna, Inc. | Long Daniel D. | SVP, Drug Discovery | M - OptEx | $2.76 | +3,333 | 99.7K | +3% | +$9,199 |
| DT | 2026-09-03 19:01 | 2026-09-01 | SEPN | Septerna, Inc. | Long Daniel D. | SVP, Drug Discovery | S - Sale+OE | $37.83 | -3,333 | 96.4K | -3% | -$126.1K |
| DMT | 2026-08-05 19:00 | 2026-08-03 | SEPN | Septerna, Inc. | Long Daniel D. | SVP, Drug Discovery | M - OptEx | $2.76 | +3,334 | 99.7K | +3% | +$9,202 |
| DMT | 2026-08-05 19:00 | 2026-08-03 | SEPN | Septerna, Inc. | Long Daniel D. | SVP, Drug Discovery | S - Sale+OE | $34.47 | -3,334 | 96.4K | -3% | -$114.9K |
| DT | 2026-07-02 19:00 | 2026-07-01 | SEPN | Septerna, Inc. | Long Daniel D. | SVP, Drug Discovery | M - OptEx | $2.76 | +3,333 | 99.7K | +3% | +$9,199 |
| DMT | 2026-07-02 19:00 | 2026-07-01 | SEPN | Septerna, Inc. | Long Daniel D. | SVP, Drug Discovery | S - Sale+OE | $34.36 | -3,333 | 96.4K | -3% | -$114.5K |
| DMT | 2026-06-24 19:24 | 2026-06-22 | SEPN | Septerna, Inc. | Long Daniel D. | SVP, Drug Discovery | M - OptEx | $5.42 | +15.0K | 111.4K | +16% | +$81.4K |
| DMT | 2026-06-24 19:24 | 2026-06-22 | SEPN | Septerna, Inc. | Long Daniel D. | SVP, Drug Discovery | S - Sale+OE | $35.51 | -15.0K | 96.4K | -13% | -$532.6K |
| 2025-11-13 | 2025-11-10 | SEPN | Septerna, Inc. | Long Daniel D. | SVP, Drug Discovery | S - Sale | $18.06 | -3,501 | 92.9K | -4% | -$63.2K |
Purchase Sale Sale after option exercise All abbreviations